Investment platform
Русский
Беларускі
Español
Curis, Inc.
Sell1.3082
Spread0.0636
Buy1.3718

Trade Curis, Inc. - CRIS stock price

Sell1.3082
Spread0.0636
Buy1.3718
1m
5m
15m
30m
1H
4H
1D
1W
History
Open on platform
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation that is in Phase Ia/Ib clinical trial in patients with solid tumors. The company''s pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma and solid tumors; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. The company was incorporated in 2000 and is headquartered in Lexington, Massachusetts.

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Download on the App Store Get it on Google Play None Explore platform Show QR
Articles
AI trading bot picks Chainlink, Toncoin, Kaspa as market recovers
Read more
1&1 to buy Versatel for €1.3b, tightening grip on German fiber
Read more
Aster unveils 2026 roadmap, plans launch of layer-1 blockchain
Read more
Can Chainlink price hit $20 as new LINK ETF inflows rise?
Read more
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

CRIS price history

  • Last 7 days
  • Last 30 days
  • Last Year
  • Last 2 Years
  • Maximum Period
  • Daily
  • Weekly
  • Monthly
Date Close Change Chg% Open Min. Max.
2022-09-30 1.3082 -0.0399 -2.96 1.3481 1.3082 1.3681
2022-09-30 1.3082 -0.0100 -0.76 1.3182 1.2682 1.3381
2022-09-30 1.2183 0.0100 0.83 1.2083 1.1783 1.2383
2022-09-30 1.1784 -0.1098 -8.52 1.2882 1.1584 1.2882
2022-09-30 1.2882 -0.0499 -3.73 1.3381 1.2283 1.3381
2022-09-30 1.3481 0.0899 7.15 1.2582 1.2582 1.3681
2022-09-30 1.2283 0.1398 12.84 1.0885 1.0885 1.2882
2022-09-30 1.1384 0.0100 0.89 1.1284 1.0984 1.1384
2022-09-30 1.1084 -0.0400 -3.48 1.1484 1.1084 1.1883
2022-09-30 1.1384 0.0799 7.55 1.0585 1.0585 1.1684
2022-09-30 1.0585 -0.0799 -7.02 1.1384 1.0585 1.1484
2022-09-30 1.0984 -0.0999 -8.34 1.1983 1.0585 1.2083
2022-09-30 1.1983 -0.0400 -3.23 1.2383 1.1883 1.2782
2022-09-30 1.2183 -0.0699 -5.43 1.2882 1.1983 1.3182
Go help.dzengi.com
Dzengi.com Exchange
Trade BTC & tokenized stocks